1. Fu, Rongrong, Xue, Wenqing, Liang, Jingjie, Zhang, Min, Meng, Jing. 2024. SOAT1 regulates cholesterol metabolism to induce EMT in hepatocellular carcinoma. In Cell death & disease, 15, 325. doi:10.1038/s41419-024-06711-9. https://pubmed.ncbi.nlm.nih.gov/38724499/
2. Sun, Shicheng, Qi, Guoliang, Chen, Hao, Guo, Hua, Zhang, Rui. 2023. Ferroptosis sensitization in glioma: exploring the regulatory mechanism of SOAT1 and its therapeutic implications. In Cell death & disease, 14, 754. doi:10.1038/s41419-023-06282-1. https://pubmed.ncbi.nlm.nih.gov/37980334/
3. Huang, Yangqing, Zhou, Xinlan, Li, Xiufen, Fang, Zhong, Ding, Rongrong. 2023. A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker. In Oncology research, 31, 193-205. doi:10.32604/or.2023.027112. https://pubmed.ncbi.nlm.nih.gov/37304239/
4. Lu, Zongji, Yuan, Zuobiao, Miyoshi, Toru, Chang, Catherine C, Shi, Weibin. 2011. Identification of Soat1 as a quantitative trait locus gene on mouse chromosome 1 contributing to hyperlipidemia. In PloS one, 6, e25344. doi:10.1371/journal.pone.0025344. https://pubmed.ncbi.nlm.nih.gov/22022387/
5. Wu, Nan, Li, Rong-Qing, Li, Li. 2018. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway. In Biochemical and biophysical research communications, 501, 343-350. doi:10.1016/j.bbrc.2018.03.137. https://pubmed.ncbi.nlm.nih.gov/29567472/
6. Kiener, Sarah, McMahill, Barbara G, Affolter, Verena K, Jagannathan, Vidhya, Leeb, Tosso. 2023. SOAT1 missense variant in two cats with sebaceous gland dysplasia. In Molecular genetics and genomics : MGG, 298, 837-843. doi:10.1007/s00438-023-02020-6. https://pubmed.ncbi.nlm.nih.gov/37060467/